In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites.

In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites.

Baek, Kyung-Hwa; Phan, Trong-Nhat; Malwal, Satish R; Lee, Hyeryon; Li, Zhu-Hong; Moreno, Silvia N J; Oldfield, Eric; No, Joo Hwan.

Afiliação

Baek KH; Host-Parasite Research Laboratory, Institut Pasteur Korea, Seongnam-si 13488, Korea.
Phan TN; Host-Parasite Research Laboratory, Institut Pasteur Korea, Seongnam-si 13488, Korea.
Malwal SR; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Lee H; Host-Parasite Research Laboratory, Institut Pasteur Korea, Seongnam-si 13488, Korea.
Li ZH; Center for Tropical and Emerging Global Diseases, Department of Cellular Biology, University of Georgia, Athens, GA 30602, USA.
Moreno SNJ; Center for Tropical and Emerging Global Diseases, Department of Cellular Biology, University of Georgia, Athens, GA 30602, USA.
Oldfield E; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
No JH; Host-Parasite Research Laboratory, Institut Pasteur Korea, Seongnam-si 13488, Korea.

Biomedicines ; 10(3)2022 Mar 14.

Article em En | MEDLINE | ID: mdl-35327472